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Scientific assessment of harmful interactions of chemicals over the entire reproductive cycle are divided into three segments based
on the period: from premating and mating to implantation (I), from implantation to major organogenesis (II), and late pregnancy
and postnatal development (III). We combined the segments I and II to assess Plathymenia reticulata aqueous extract safety. In
order to investigate reproductive toxicity (segment I), pregnant rats received orally 0.5 or 1.0 g/kg of extract, daily, during 18 days.
These concentrations were determined by a preliminary in vitro LD50 test in CHO-k1 cells. A control group received deionized
water. The offspring was removed at the 19th day, by caesarean, and a teratology study (segment II) was carried out. The corpora
lutea, implants, resorptions, live, and dead fetuses were then counted. Placenta and fetuses were weighted. External and visceral
morphology were provided by the fixation of fetuses in Bouin, whereas skeletal analysis was carried out on the diaphanizated ones.
The increase in the weights of placenta and fetuses was the only abnormality observed. Since there was no sign of alteration on
reproduction parameters at our experimental conditions, we conclude that P. reticulata aqueous extract is safe at 0.5 to 1.0 g/kg and
is not considered teratogenic.
1. Introduction
Plathymenia reticulata Benth (Leguminosae) is a plant pop-
ularly known as “vinha´tico” (wine-like), found in “Cerrado”
region in Brazil, and represents a good source of high quality
wood.The plant coevolution with other species has led to the
development of secondary metabolites for its self-defenses
against pathogens (viruses, bacteria, and fungi) and predators
like insects and mammals.
Among several secondary metabolites identified in P. re-
ticulata trunk heartwood, plathyterpol [1], vinhaticyl acetate,
and methyl vinhaticoate [2], 16,18-diacetoxycass-13(15)-ene
and 16-hidroxy-18-acetoxycass-13(15)-ene [3] are the most
common. The medicinal potential of P. reticulata as anti-
inflammatory [4], antimicrobial [5, 6], and depurative of
blood [7] is also highlighted by the inherent presence of tan-
nins, flavonoids [5], and cassane diterpenes in its constitution
[3].
However, in spite of their medicinal potential, secondary
metabolites synthesized by plants can also be harmful for the
aggressor. In mammals, they can induce toxicity to a number
of different organs including skin, lung, liver, kidney and
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bladder, blood, skeletal muscle, and central and peripheral
nervous systems including the neuromuscular junctions [8].
In vitro studies showed that P. reticulata barks hydroalco-
holic extract inhibits the irreversible neuromuscular blockade
induced by Bothrops jararacussu (79.3 ± 7.5%) and Crotalus
durissus terrificus (73.2±6.7%) venoms, onmouse neuromus-
cular junctions. This antivenom activity was mainly related
to protein precipitation caused by the high content of tannins
(4%) present in the extract [9].
Using mouse skeletal muscles, further investigations
upon the anti-snake venom profile of P. reticulata barks
secondary metabolites showed that the dichloromethane
extract (0.4mg/mL) inhibited the throphic muscle effects
induced by Bothrops jararacussu venom [10].
In an attempt of investigating the risk assessment of
P. reticulata, its mutagenic potential was evaluated by the
Salmonellamutagenicity assay (Ames test) and the micronu-
cleus test in CHO-K1 cells. Although the hydroalcoholic
extract of P. reticulata barks showed mutagenicity, the Ames
test also unveiled its anticarcinogenic potential [11].
In Brazil, local markets frequently sell herbal medicinal
plants, in which tannin-rich trees, like P. reticulata, are
commonly found. Plants rich in tannins are also described for
treating diarrhea, hypertension, wounds, burns, kidney and
stomach diseases, and inflammation [12]. However, in spite
of their obvious clinical benefits, the oral administration of
these remedies, associated with the lack of scientific proof of
safety, put in risk the population health. Besides the potential
adverse effects caused by the herb itself, teratogenicity is
another important concern.
During pregnancy, one of the results of acute or chronic
exposure to naturally occurring chemical agents can be
an abnormal offspring development. Manifestations of the
developmental toxicity include structural malformations,
growth retardation, functional impairment, and/or death of
the organism [13].
In this work we showed the safety evaluation of P. retic-
ulata aqueous extract using developmental and reproductive
toxicology protocols (segments I and II).
2. Materials and Methods
2.1. Vegetal Material and Extraction Procedure. Samples of
P. reticulata Benth bark were collected from Miracema city
herbarium (Miracema, Tocantins, Brazil) in December 2007.
The specimens were deposited (protocols NRHTO 3327)
at the herbarium of Federal University of Tocantins. The
bark was dried at 40∘C in an incubator with forced air
circulation apparatus for 48 hours. The material was ground
in amill (MA 340,Marconi, Brazil), macerated for seven days
(1276.32 g) in 70% ethanol (14.5 liters), and the suspension
was protected from light and percolated at 20 drops/minute,
resulting in a 20% (w/v) hydroalcoholic extract. This pro-
cedure was previously described by Farrapo et al. [10] and
Della Torre et al. [11]. Briefly, the obtained extract contained
3.75%polyphenols and 0.16%flavonoids and showed positive
reactions to tannins.The resulting material was concentrated
in a rotary evaporator (TE-210, Tecnal, Brazil) and lyophilized
(Multitasking Freeze Drying S, SNL216V-115, Thermo Fisher
Scientific, USA).
2.2. Cell Line and Culture Conditions. As described by Della
Torre et al. [11], Chinese hamster ovary cells (CHO-K1
lineage, American Type Cell Culture, ATCC number CCL-
61) were maintained at 37∘C in 5% CO
2
and 97% humidity
in RPMI 1640 culture medium (Gibco, USA), supplemented
with 10% (v/v) fetal bovine serum (FBS, Gibco), 1% (v/v) L-
glutamine (L-Glu, Gibco), 1% (v/v) penicillin streptomycin
(PS, Gibco) and 0.1% (v/v) amphotericin B (Gibco). For
subculturing and experiments, the cells were harvested using
0.05% (w/v) trypsin and 0.02% (w/v) ethylene diamine
tetracetic acid (EDTA) in a saline phosphate-buffered solu-
tion, pH 7.4. Each trypsinizationwas recorded as one passage.
The test was performed at the third passage.
2.3. Cytotoxicity Evaluation (IC10 and IC50). Thecytotoxicity
evaluationwas carried out by using the CellTiter 96 AQueous
Non-radioactive Cell Proliferation Assay (Promega,
Madison, WI, USA), in which 3-(4,5-dimethylthiazol-
2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulphophenyl)-2H-
tetrazolium, inner salt (MTS) is bioreduced to formazan
by dehydrogenase enzymes in metabolically active cells.
The amount of formazan produced by the cells was
determined by measuring sample absorbance at 490 nm
with a spectrophotometer SpectraMax 190 (Molecular
Devices, Sa˜o Paulo, SP, Brazil). Statistical analysis of data was
performed by using one-way analysis of variance (ANOVA)
between two different sample curves and solvent control
curve. The binomial proportion confidence interval was
adopted.
2.4. In Vitro LD50 of P. reticulata Barks Lyophilized Extract.
The value of the LD50 (Lethal Dose to kill 50% of animals),
an essential test for the controlled use of animals of assays in
vivo, was determined in P. reticulata barks lyophilized extract.
In this assay, the inhibitory concentration that kills 50% of
the cells (IC 50), was (0.331mgmL−1), as describe by Della
Torre et al. [15]. Applying the formula: log [LD50 (mgmL−1)]
= 0.372 × log IC50 (𝜇g mL−1) +2.024 [16, 17], the value of
the LD50 was calculated in order to orientate the in vivo
experimental assays.
2.5. In Vivo Experiment
2.5.1. P. reticulata Aqueous Extract Preparation. The P. retic-
ulata aqueous extract, to be administered via gavage in rats,
was prepared daily using the previous lyophilized extract (see
plant material and extraction) dissolved in deionized water.
2.5.2. Animals. Six males and fifteen female adult Wistar rats
weighing 160 g to 200 g were supplied by Anilab, Animais
de Laborato´rio (Paul´ınia, Sa˜o Paulo, Brazil). All animals
were maintained in groups (5 rats per cage), previously
housed to laboratory conditions during one week before
the experiments at 25 ± 3∘C on a 12 h light/dark cycle
and had access to food and water ad libitum. This project
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(protocol number A011/CEP/2008) was approved by the
institutional Committee for Ethics in Research of Vale do
Paraiba University (UNIVAP), and the experiments were
carried out according to the guidelines of the Brazilian
College for Animal Experimentation.
2.5.3. The Reproduction and Fertility Study (Segment I). The
method for reproductive evaluation was previously described
elsewhere [18–20]. Briefly, 15 sexually naive rat females were
mated with males (five females with two males per cage).
Pregnancy was confirmed through the presence of sperma-
tozoids in vaginal-washing rubbing observed by microscopy
analysis [21]. The presence of spermatozoids was considered
as the first day of pregnancy. Each pregnant femalewas kept in
separate cage.Three experimental groups were analyzed, two
treated and one control. The animals had free access to water
and food during all the experiment and the consumption was
monitored daily. For reproductive evaluation, each group of 5
females received 0.5 g/kg/day (group 1) or 1.0 g/kg/day (group
2) ofP. reticulata extract or deionizedwater (group 3, control),
from the first to the 18∘ day of pregnancy. The weight gain of
pregnant females was monitored during the pregnancy.
2.5.4. The Teratology Study (Segment II). For the teratogenic
study each group of 5 females received by gavage 0.5 g/kg/day
(group 1), 1.0 g/kg/day (group 2) of P. reticulata extract, or
deionized water (group 3) from days 1 to 18 of pregnancy.
Pregnant rats were anesthetized with halothane (Halotano,
Cristalia, Brazil), killed, and submitted to a rapidly exci-
sion of their uterus. The following macroscopic parameters
were evaluated in order to observe the reproductive perfor-
mance of rats [22]: (1) placenta weight (grams); (2) fetus
weight (grams); (3) preimplantation loss (%) = corpora lutea
number − implantation number/corpora lutea number; (4)
postimplantation loss (%) = implantation number − alive
fetus/implantation number; and (5) offspring vitality (%).
The offspring was anesthetized with halothane, killed,
and fixed in Bouin’s solution for 24–48 h, replaced by 70%
hydroalcoholic solution.The following parameters weremea-
sured (cm): A: craniocaudal; B: tail; C: anteroposterior of
cranio; D: laterolateral of cranio; E: anteroposterior of thorax;
and F: laterolateral of thorax. The other offspring group
was anesthetized with halothane, killed, eviscerated, and
diaphanizated for posterior skeletal examination. The fetuses
selected were fixed in ethanol, then “cleared” and stained by
a KOH alizarin red-S technique [23]. Examination included
enumeration of the vertebra, ribs, and other bone structures,
degree of ossification, and any fusions or abnormalities in
bone shape or position [24].
2.6. Statistical Analysis. Data from the different assays were
first analyzed regarding distribution and variance homogene-
ity. Normally distributed data were submitted to comparison
between both groups by using Student’s 𝑡-test. Nonnor-
mally distributed data were first transformed (log). One-way
ANOVA or Fisher’s exact tests were used for evaluation of
physical development parameters. Significance level was set
as 5%.
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Figure 1: Effect of P. reticulata hydroalcoholic extract against
Chinese hamster ovary cell viability (%). The graph shows the
cell viability versus different concentrations of P. reticulata extract
(mg/mL).The IC10 valuewas estimated in 0.113mg/mL and the IC50
in 0.331mg/mL, calculated via Phototox software program [14].
3. Results and Discussion
This study was designed to evaluate the safety of oral
administration of P. reticulata aqueous extract in pregnant
rats.
A prerequisite for understanding the abnormal develop-
ment in mammals is the evaluation of the normal develop-
ment that, in turn, is characterized by changes such as size,
biochemistry and physiology, and in shape and functionality.
In this view, gametogenesis is the process of forming the
haploid germ cells, the egg, and sperm. These gametes fuse
in the process of fertilization to form the diploid zygote,the
embryo. It is well known that, in developmental toxicity
studies, the major effects of prenatal exposure of a chemical
compound are observed at the time of birth as embryolethal-
ity, malformations, and growth retardation. A disturbance
on a single cell may induce an abnormal development at the
zygote (one-cell) stage, the blastocyst stage (when only a few
cells in the inner cell mass are embryo progenitors), or during
organogenesis, when organ rudiments may consist of only
few cells. Nevertheless, the relationship between these effects
is too complex to evaluate and varies with the type of agent,
the time of exposure, and the dose of the toxic compound [13].
Figure 1 shows the cell viability (%) compared to different
plant extract concentrations. The value of IC10 was found
to be 0.113mg/mL, accounting for the concentration at
which approximately 90% of cells survived (noncytotoxic
concentration). The IC50 of 0.331mg/mL corresponds to
the concentration at which approximately 50% of the cells
survived.
De Toledo et al. [6] evaluated Plathymenia reticulata
cytotoxicity using VERO cells and found a cytotoxic concen-
tration (CC50) of 156.67 𝜇g/mL. A possible explanation for
these different values may relay in the different cell line used
and also the different colorimetric assays.
According to ICCVAM [16], the LD50 value can be
determined based on the IC50, by applying the following
formula: log LD50 (mg/kg) = 0.372 log IC50 (𝜇g/mL) + 2.024.
Thus, the advantages of using this analysis are the reduction
of animal use during in vivo tests [14], and the knowledge
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Figure 2: Effect of P. reticulata aqueous extract on weight gain of
pregnant rats. On the graph each bar is the mean ± S.E.M. of five
experiments. Note that there were no significant changes (𝑃 > 0.05,
𝑡-test, and one-way ANOVA test were applied in this assay) between
the P. reticulata-treated and control groups.
A B C D E F
M
ea
su
re
s (
cm
)
25
20
15
10
5
0
∗
Control group
0.5 g/kg P. reticulata aqueous extract
1.0 g/kg P. reticulata aqueous extract
∗
∗ ∗
∗
∗
∗
∗
∗ ∗ ∗ ∗
Figure 3: Effect of P. reticulata aqueous extract (0.5 g/kg and
1.0 g/kg) against the externalmorphological parameters of offspring.
The graph is the mean ± S.E.M. of five experiments. (A: craniocau-
dal; B: tail; C: anteroposterior of cranio; D: laterolateral of cranio; E:
anteroposterior of thorax; and F: laterolateral of thorax.) ∗𝑃 < 0.05
compared to control group.
of the initial dose for in vivo studies, mainly when LD50
tests for acute oral toxicity, is required. Nowadays, most of
the toxicological studies involving new drugs combine in
vivo and in vitro assays in order to increase safety (i.e., in
the case of a further approval for clinical use). For example,
the evaluation of the development and safety of medicinal
products require the estimation of IC50 values [17]. In our
experimental conditions, together with the IC50 values in
CHO-K1 cells, it was calculated the LD50 as 915mg/kg.
Table 1: Reproductive performance of pregnant rats exposed to
Plathymenia reticulata aqueous extract.
Teratogenicity
parameters Control
Experimental
0.5 g/kg
Experimental
1.0 g/kg
Preimplantation loss
(%) 0 0 0
Postimplantation loss
(%) 0 1.69 5.55
Placenta weight
(grams)
0.494 ± 0.07
(𝑛 = 59)
0.542 ± 0.09∗
(𝑛 = 58)
0.530 ± 0.07∗
(𝑛 = 51)
Fetus weight (grams) 1.336 ± 0.25(𝑛 = 59)
1.433 ± 0.20∗
(𝑛 = 58)
1.456 ± 0.15∗
(𝑛 = 51)
∗
𝑃 < 0.05.
The above calculations applied to the in vivo experimental
assays permitted the determination of two concentrations
(0.5 and 1 g/kg) of P. reticulata extract, thatmimics the human
consumption.
Figure 2 shows the graph of mean (±S.E.M.) weight
gain during the gestation, considering water ingestion and
food consumption ad libitum. At the 95% confidence level
the two means (control compared to P. reticulata extracts)
are not significantly different. The weight losses of control
pregnant rats and treated groups and also of 6–10th day of
pregnancy compared to 1–5th day can be explained by the
habituation phenomenon [25], since rats are very sensitive to
manipulation.
The relationship between maternal and developmental
toxicity is not only a result of an insult to the conceptus
at the cellular level. Insults may occur through different
routes, including a direct effect on the embryo/fetus, indirect
toxicity of the agent to the mother through the placenta,
or a combination of direct and indirect effects. Maternal
conditions could potentially harm the developing organism
by altering the nutritional status, among several different
factors [26, 27].
It is well known that intergenerational malnutrition is
responsible for reducing the gain of weight during pregnancy
in rats [28]. Therefore, the distinction between direct and
indirect developmental toxicity is important to understand
safety assessment tests in pregnant animals. In our experi-
mental conditions, all animals had access to food and water
ad libitum, in order to exclude this variable (Figure 3). Here,
the concentrations assayed did not induce maternal toxicity.
According to Rogers and Kavlock [13], a decrease in food
or water intake would induce weight loss and other clinical
signs. As an example, they have shown a significant maternal
weight reduction at the end of pregnancy in the sibutramine
nonoverweight drug-treated group, compared to the control
(nonoverweight, no drug). This data can be linked to a
significant increase in post-implantation loss and placental
index, suggesting that sibutramine alone or the condition
of excess weight in the absence of drugs has altered the
reproductive performance [15].
The reproductive performance can be also evaluated by
macroscopic parameters such as placenta weight (grams),
BioMed Research International 5
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Figure 4: Representative pictures of 19th days gestation fetuses for teratogenicity test. Pregnant rats were treated daily with P. reticulata
(1.0 g/kg) and the offspring removed surgically prior to birth. Diaphanizated fetuses were analyzed by lateral (a), posterior (b), and frontal
(c) views. The parameters of sternum ossification (S), clavicule (CL), cranio (CR), pelvis (PE), mandible (M), and vertebral spine (VS) were
examined. Notice that no abnormality was observed.
fetus weight (grams), preimplantation loss (%), postimplan-
tation loss, and offspring vitality (%). Regarding this later
information, the data after administration of P. reticulata
aqueous extract (0.5 g/kg or 1 g/kg) did not differ from control
group (Table 1), except for placenta and fetuses weights.
Under these parameters, P. reticulata treatment increased the
gain (in grams) of placenta and fetuses. According to Langley
and Jackson [29], low-protein intake induces intrauterine
protein restriction during diet that could explain the gain
(in grams) of placenta and fetuses in P. reticulata treatment.
However, in our experimental conditions animals had access
to food and water ad libitum. According to des Robert et al.
[30], high protein intake via the enteral route could explain
the enhanced weight gain in P. reticulata treatment.
The external morphological parameters of offspring were
measured and compared to control group. All parameters
evaluated were statistically different to the control, but not
between the experimental treated-groups, via mother, that
received 0.5 g/kg or 1.0 g/kg of P. reticulata aqueous extract
(Figure 3).
No abnormality was seen in fetuses, except with the off-
spring sizes, demonstrating the safety of P. reticulata aqueous
extract, in our experimental conditions. When cyclophos-
phamide (40mg/kg), a well-known teratogenic agent, was
used as a positive control, a strong teratogenic activity was
observed (a dose 12.5 and 25 times lower than 0.5 and 1.0 g/kg
P. reticulata, resp.). At this concentration cyclophosphamide
was able to induce high resorption rate (approximately, 80%)
and severe fetal malformations with retarded growth. These
later phenomena were traduced by craniofacial alterations
such as severemicrocephaly, agnathia, open eyes, limb reduc-
tion, and trunk anomalies such as phocomelia or amelia, as
well as, eventration of the abdominal wall and absence of the
tail. Even at 15mg/kg of cyclophosphamide, the teratogenic
effect was observed in 70% of fetuses, which exhibited
external tail and digit anomalies, such as short or crooked tail,
syndactyly and ectrodactyly [31].
The analysis of external morphology carried out in
conceptus exposed to P. reticulata aqueous extract (0.5 g/kg
or 1/0 g/kg) just prior to birth showed no abnormalities upon
skeletal examination of diaphanizated fetuses (Figure 4). The
parameters analyzed were soft tissues, cartilage calcification,
vertebra and ribs quantification, bone shape or position, ster-
num ossification (S), and bones such as cranium (CR), pelvis
(PE), vertebral spine (VS), clavicule (CL), and mandible (M).
Visceral malformations were not observed in organs such
as liver, stomach, duodene, and kidneys. Morphological anal-
ysis in the head and neck regions showed that all structures
were correctly implanted. The observation of structures such
as palate, nostrils, ocular globe, inner ear, cortex, cerebral
ventricle, marrow, trachea, and esophagus showed no sign of
alterations; the oral cavity was delimited by palate and was
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Figure 5: Representative sections from head and neck regions of fetuses exposed to P. reticulata aqueous extract (1.0 g/kg). Oral region
transversally sectioned: 1: palate; 2: trachea; 3: inner ear; 4: marrow. Nasal region frontally sectioned: 5: nasal cavity; 6: nasal septum; 7: palate.
Cerebral hemispheres region frontally sectioned: 8: cerebral hemisphere; 9: ventricles; 10: diencephalon. Eyes region frontally sectioned: 11:
cornea; 12: retina; 13: olfactory bulb; 14: crystalline. After a careful analysis of the anatomical parameters, no abnormality was observed among
the groups.
not obstructed in all fetuses examined, treated groups, and
control group (Figure 5).
This study also included the daily observation of pregnant
rats to a previous oral administration of P. reticulata aqueous
extract (0.5 g/kg or 1.0 g/kg). In this protocol there were no
signs of increased hair loss, excessive salivation, alteration
in respiration, and abnormal gaits, tremors, or seizures.
Although the gain of weight (grams) of pregnant rats was
not statistically different (treated groups compared to the
control group), therewere significative changes in theweights
of placenta and fetuses (𝑛 = S.E.M., ∗𝑃 < 0.05). The fetal
evaluation between treated and control groups showed no
malformations, defined as “those structural anomalies that
alter general body conformity, disrupt or interfere with body
function, or are generally thought to be incompatible with
life” [32].
4. Conclusions
Overall the results suggest that oral administration of P.
reticulata aqueous extract at 0.5 and 1.0 g/kg is safe, related
to reproduction and fertility parameters or even in terms
of inducing teratogenicity. This paper also shows that the
combination of in vitro assays to select the dosage, with in
vivo experiments, which involved the segment I (the period
of premating and mating to implantation) and segment II
(the period from implantation to major organogenesis), can
be useful for assessing safety parameters of new medicinal
compounds.
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